← back to search

Sven O Tröbs

Boehringer Ingelheim (Germany) · DE
Area of research
Cardiology and Cardiovascular Medicine · Complementary and alternative medicine
Research interest
Research interests include Cardiovascular Function and Risk Factors, Cardiovascular and exercise physiology, Heart Failure Treatment and Management, and Cardiovascular Disease and Adiposity.
h-index
1
citations
2
works
3
NIH funding
primary concept
email

Recent publications

Role of Heart Rate Recovery in Chronic Heart Failure: Results From the MyoVasc Study
Journal of the American Heart Association 2025cited by 5position: middledoi
Personalized app-based coaching for improving physical activity in heart failure with preserved ejection fraction patients compared with standard care: rationale and design of the MyoMobile Study
European Heart Journal - Digital Health 2025cited by 2position: middledoi
Heart rate variability: reference values and role for clinical profile and mortality in individuals with heart failure
Clinical Research in Cardiology 2023cited by 43position: middledoi
Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus—results from the randomized, double-blind, placebo-controlled EmDia trial
Clinical Research in Cardiology 2023cited by 19position: middledoi
Association of Global Longitudinal Strain With Clinical Status and Mortality in Patients With Chronic Heart Failure
JAMA Cardiology 2021cited by 45position: firstdoi
The Impact of Platelet Indices on Clinical Outcome in Heart Failure: Results from the MyoVasc Study
ESC Heart Failure 2021cited by 44position: middledoi
Cardiovascular profiling in the diabetic continuum: results from the population-based Gutenberg Health Study
Clinical Research in Cardiology 2021cited by 20position: middledoi
Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population
Journal of Clinical Medicine 2021cited by 20position: middledoi
Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
Scientific Reports 2021cited by 13position: middledoi
FEV1 Predicts Cardiac Status and Outcome in Chronic Heart Failure
CHEST Journal 2021cited by 9position: middledoi
Rationale, design and baseline characteristics of the MyoVasc study: A prospective cohort study investigating development and progression of heart failure
European Journal of Preventive Cardiology 2020cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen H. Prochaska · University Hospital and Clinics11 papers (2020–2025)Philipp S. Wild · Papworth Hospital11 papers (2020–2025)Karl J. Lackner · Johannes Gutenberg University Mainz10 papers (2020–2025)Thomas Münzel · Medical Genetics Center9 papers (2020–2023)Andreas Schulz · Gilead Sciences (United States)8 papers (2021–2025)Tommaso Gori · Johannes Gutenberg University Mainz7 papers (2020–2025)Felix Müller · Humboldt-Universität zu Berlin5 papers (2021–2025)Marc Heidorn · Johannes Gutenberg University Mainz5 papers (2021–2025)Alexander Schuch · Johannes Gutenberg University Mainz4 papers (2021–2025)Konstantin Strauch · University Medical Centre Mannheim4 papers (2021–2023)Karsten Keller · Leiden University Medical Center3 papers (2021–2021)Sebastian Göbel · Johannes Gutenberg University Mainz3 papers (2020–2021)Gregor Buch · Johannes Gutenberg University Mainz3 papers (2021–2025)Omar Hahad · Medical Genetics Center3 papers (2021–2021)Silav Zeid · Johannes Gutenberg University Mainz3 papers (2023–2025)Natalie Arnold · Universität Hamburg3 papers (2021–2023)Volker H. Schmitt · Johannes Gutenberg University Mainz3 papers (2021–2021)Marina Panova‐Noeva · Boehringer Ingelheim (Australia)3 papers (2020–2021)Sören Schwuchow‐Thonke · Johannes Gutenberg University Mainz3 papers (2021–2021)Matthias Michal · University Medical Center Hamburg-Eppendorf3 papers (2020–2025)